Global Dendritic Cell Cancer Vaccine Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Dendritic Cell Cancer Vaccine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Dendritic Cell Cancer Vaccine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Dendritic Cell Cancer Vaccine by Country/Region, 2017, 2022 & 2028

2.2 Dendritic Cell Cancer Vaccine Segment by Type

2.2.1 CreaVax

2.2.2 Sipuleucel-T (Provenge)

2.2.3 Others

2.3 Dendritic Cell Cancer Vaccine Sales by Type

2.3.1 Global Dendritic Cell Cancer Vaccine Sales Market Share by Type (2017-2022)

2.3.2 Global Dendritic Cell Cancer Vaccine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Dendritic Cell Cancer Vaccine Sale Price by Type (2017-2022)

2.4 Dendritic Cell Cancer Vaccine Segment by Application

2.4.1 Pediatrics

2.4.2 Adults

2.5 Dendritic Cell Cancer Vaccine Sales by Application

2.5.1 Global Dendritic Cell Cancer Vaccine Sale Market Share by Application (2017-2022)

2.5.2 Global Dendritic Cell Cancer Vaccine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Dendritic Cell Cancer Vaccine Sale Price by Application (2017-2022)

3 Global Dendritic Cell Cancer Vaccine by Company

3.1 Global Dendritic Cell Cancer Vaccine Breakdown Data by Company

3.1.1 Global Dendritic Cell Cancer Vaccine Annual Sales by Company (2020-2022)

3.1.2 Global Dendritic Cell Cancer Vaccine Sales Market Share by Company (2020-2022)

3.2 Global Dendritic Cell Cancer Vaccine Annual Revenue by Company (2020-2022)

3.2.1 Global Dendritic Cell Cancer Vaccine Revenue by Company (2020-2022)

3.2.2 Global Dendritic Cell Cancer Vaccine Revenue Market Share by Company (2020-2022)

3.3 Global Dendritic Cell Cancer Vaccine Sale Price by Company

3.4 Key Manufacturers Dendritic Cell Cancer Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Dendritic Cell Cancer Vaccine Product Location Distribution

3.4.2 Players Dendritic Cell Cancer Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Dendritic Cell Cancer Vaccine by Geographic Region

4.1 World Historic Dendritic Cell Cancer Vaccine Market Size by Geographic Region (2017-2022)

4.1.1 Global Dendritic Cell Cancer Vaccine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Dendritic Cell Cancer Vaccine Annual Revenue by Geographic Region

4.2 World Historic Dendritic Cell Cancer Vaccine Market Size by Country/Region (2017-2022)

4.2.1 Global Dendritic Cell Cancer Vaccine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Dendritic Cell Cancer Vaccine Annual Revenue by Country/Region

4.3 Americas Dendritic Cell Cancer Vaccine Sales Growth

4.4 APAC Dendritic Cell Cancer Vaccine Sales Growth

4.5 Europe Dendritic Cell Cancer Vaccine Sales Growth

4.6 Middle East & Africa Dendritic Cell Cancer Vaccine Sales Growth

5 Americas

5.1 Americas Dendritic Cell Cancer Vaccine Sales by Country

5.1.1 Americas Dendritic Cell Cancer Vaccine Sales by Country (2017-2022)

5.1.2 Americas Dendritic Cell Cancer Vaccine Revenue by Country (2017-2022)

5.2 Americas Dendritic Cell Cancer Vaccine Sales by Type

5.3 Americas Dendritic Cell Cancer Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Dendritic Cell Cancer Vaccine Sales by Region

6.1.1 APAC Dendritic Cell Cancer Vaccine Sales by Region (2017-2022)

6.1.2 APAC Dendritic Cell Cancer Vaccine Revenue by Region (2017-2022)

6.2 APAC Dendritic Cell Cancer Vaccine Sales by Type

6.3 APAC Dendritic Cell Cancer Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Dendritic Cell Cancer Vaccine by Country

7.1.1 Europe Dendritic Cell Cancer Vaccine Sales by Country (2017-2022)

7.1.2 Europe Dendritic Cell Cancer Vaccine Revenue by Country (2017-2022)

7.2 Europe Dendritic Cell Cancer Vaccine Sales by Type

7.3 Europe Dendritic Cell Cancer Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Dendritic Cell Cancer Vaccine by Country

8.1.1 Middle East & Africa Dendritic Cell Cancer Vaccine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Dendritic Cell Cancer Vaccine Revenue by Country (2017-2022)

8.2 Middle East & Africa Dendritic Cell Cancer Vaccine Sales by Type

8.3 Middle East & Africa Dendritic Cell Cancer Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Dendritic Cell Cancer Vaccine

10.3 Manufacturing Process Analysis of Dendritic Cell Cancer Vaccine

10.4 Industry Chain Structure of Dendritic Cell Cancer Vaccine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Dendritic Cell Cancer Vaccine Distributors

11.3 Dendritic Cell Cancer Vaccine Customer

12 World Forecast Review for Dendritic Cell Cancer Vaccine by Geographic Region

12.1 Global Dendritic Cell Cancer Vaccine Market Size Forecast by Region

12.1.1 Global Dendritic Cell Cancer Vaccine Forecast by Region (2023-2028)

12.1.2 Global Dendritic Cell Cancer Vaccine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Dendritic Cell Cancer Vaccine Forecast by Type

12.7 Global Dendritic Cell Cancer Vaccine Forecast by Application

13 Key Players Analysis

13.1 Activarti

13.1.1 Activarti Company Information

13.1.2 Activarti Dendritic Cell Cancer Vaccine Product Offered

13.1.3 Activarti Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Activarti Main Business Overview

13.1.5 Activarti Latest Developments

13.2 Argos Therapeutics

13.2.1 Argos Therapeutics Company Information

13.2.2 Argos Therapeutics Dendritic Cell Cancer Vaccine Product Offered

13.2.3 Argos Therapeutics Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Argos Therapeutics Main Business Overview

13.2.5 Argos Therapeutics Latest Developments

13.3 SOTIO (Acquired by PPF Group)

13.3.1 SOTIO (Acquired by PPF Group) Company Information

13.3.2 SOTIO (Acquired by PPF Group) Dendritic Cell Cancer Vaccine Product Offered

13.3.3 SOTIO (Acquired by PPF Group) Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 SOTIO (Acquired by PPF Group) Main Business Overview

13.3.5 SOTIO (Acquired by PPF Group) Latest Developments

13.4 Bellicum Pharmaceuticals

13.4.1 Bellicum Pharmaceuticals Company Information

13.4.2 Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Product Offered

13.4.3 Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Bellicum Pharmaceuticals Main Business Overview

13.4.5 Bellicum Pharmaceuticals Latest Developments

13.5 JW CreaGene

13.5.1 JW CreaGene Company Information

13.5.2 JW CreaGene Dendritic Cell Cancer Vaccine Product Offered

13.5.3 JW CreaGene Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 JW CreaGene Main Business Overview

13.5.5 JW CreaGene Latest Developments

13.6 DanDrit

13.6.1 DanDrit Company Information

13.6.2 DanDrit Dendritic Cell Cancer Vaccine Product Offered

13.6.3 DanDrit Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 DanDrit Main Business Overview

13.6.5 DanDrit Latest Developments

13.7 DCPrime

13.7.1 DCPrime Company Information

13.7.2 DCPrime Dendritic Cell Cancer Vaccine Product Offered

13.7.3 DCPrime Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 DCPrime Main Business Overview

13.7.5 DCPrime Latest Developments

13.8 Elios Therapeutics

13.8.1 Elios Therapeutics Company Information

13.8.2 Elios Therapeutics Dendritic Cell Cancer Vaccine Product Offered

13.8.3 Elios Therapeutics Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Elios Therapeutics Main Business Overview

13.8.5 Elios Therapeutics Latest Developments

13.9 ImmunoCellular Therapeutics

13.9.1 ImmunoCellular Therapeutics Company Information

13.9.2 ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccine Product Offered

13.9.3 ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 ImmunoCellular Therapeutics Main Business Overview

13.9.5 ImmunoCellular Therapeutics Latest Developments

13.10 Kiromic

13.10.1 Kiromic Company Information

13.10.2 Kiromic Dendritic Cell Cancer Vaccine Product Offered

13.10.3 Kiromic Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Kiromic Main Business Overview

13.10.5 Kiromic Latest Developments

13.11 Medigene

13.11.1 Medigene Company Information

13.11.2 Medigene Dendritic Cell Cancer Vaccine Product Offered

13.11.3 Medigene Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Medigene Main Business Overview

13.11.5 Medigene Latest Developments

13.12 Merck

13.12.1 Merck Company Information

13.12.2 Merck Dendritic Cell Cancer Vaccine Product Offered

13.12.3 Merck Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Merck Main Business Overview

13.12.5 Merck Latest Developments

13.13 Northwest Biotherapeutics

13.13.1 Northwest Biotherapeutics Company Information

13.13.2 Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Product Offered

13.13.3 Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Northwest Biotherapeutics Main Business Overview

13.13.5 Northwest Biotherapeutics Latest Developments

13.14 Immutep Limited

13.14.1 Immutep Limited Company Information

13.14.2 Immutep Limited Dendritic Cell Cancer Vaccine Product Offered

13.14.3 Immutep Limited Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Immutep Limited Main Business Overview

13.14.5 Immutep Limited Latest Developments

13.15 Dendreon Corporation

13.15.1 Dendreon Corporation Company Information

13.15.2 Dendreon Corporation Dendritic Cell Cancer Vaccine Product Offered

13.15.3 Dendreon Corporation Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Dendreon Corporation Main Business Overview

13.15.5 Dendreon Corporation Latest Developments

13.16 Oncobiomed

13.16.1 Oncobiomed Company Information

13.16.2 Oncobiomed Dendritic Cell Cancer Vaccine Product Offered

13.16.3 Oncobiomed Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Oncobiomed Main Business Overview

13.16.5 Oncobiomed Latest Developments

14 Research Findings and Conclusion

Table 1. Dendritic Cell Cancer Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Dendritic Cell Cancer Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of CreaVax

Table 4. Major Players of Sipuleucel-T (Provenge)

Table 5. Major Players of Others

Table 6. Global Dendritic Cell Cancer Vaccine Sales by Type (2017-2022) & (K Doses)

Table 7. Global Dendritic Cell Cancer Vaccine Sales Market Share by Type (2017-2022)

Table 8. Global Dendritic Cell Cancer Vaccine Revenue by Type (2017-2022) & ($ million)

Table 9. Global Dendritic Cell Cancer Vaccine Revenue Market Share by Type (2017-2022)

Table 10. Global Dendritic Cell Cancer Vaccine Sale Price by Type (2017-2022) & (USD/Dose)

Table 11. Global Dendritic Cell Cancer Vaccine Sales by Application (2017-2022) & (K Doses)

Table 12. Global Dendritic Cell Cancer Vaccine Sales Market Share by Application (2017-2022)

Table 13. Global Dendritic Cell Cancer Vaccine Revenue by Application (2017-2022)

Table 14. Global Dendritic Cell Cancer Vaccine Revenue Market Share by Application (2017-2022)

Table 15. Global Dendritic Cell Cancer Vaccine Sale Price by Application (2017-2022) & (USD/Dose)

Table 16. Global Dendritic Cell Cancer Vaccine Sales by Company (2020-2022) & (K Doses)

Table 17. Global Dendritic Cell Cancer Vaccine Sales Market Share by Company (2020-2022)

Table 18. Global Dendritic Cell Cancer Vaccine Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Dendritic Cell Cancer Vaccine Revenue Market Share by Company (2020-2022)

Table 20. Global Dendritic Cell Cancer Vaccine Sale Price by Company (2020-2022) & (USD/Dose)

Table 21. Key Manufacturers Dendritic Cell Cancer Vaccine Producing Area Distribution and Sales Area

Table 22. Players Dendritic Cell Cancer Vaccine Products Offered

Table 23. Dendritic Cell Cancer Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Dendritic Cell Cancer Vaccine Sales by Geographic Region (2017-2022) & (K Doses)

Table 27. Global Dendritic Cell Cancer Vaccine Sales Market Share Geographic Region (2017-2022)

Table 28. Global Dendritic Cell Cancer Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Dendritic Cell Cancer Vaccine Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Dendritic Cell Cancer Vaccine Sales by Country/Region (2017-2022) & (K Doses)

Table 31. Global Dendritic Cell Cancer Vaccine Sales Market Share by Country/Region (2017-2022)

Table 32. Global Dendritic Cell Cancer Vaccine Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Dendritic Cell Cancer Vaccine Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Dendritic Cell Cancer Vaccine Sales by Country (2017-2022) & (K Doses)

Table 35. Americas Dendritic Cell Cancer Vaccine Sales Market Share by Country (2017-2022)

Table 36. Americas Dendritic Cell Cancer Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Dendritic Cell Cancer Vaccine Revenue Market Share by Country (2017-2022)

Table 38. Americas Dendritic Cell Cancer Vaccine Sales by Type (2017-2022) & (K Doses)

Table 39. Americas Dendritic Cell Cancer Vaccine Sales Market Share by Type (2017-2022)

Table 40. Americas Dendritic Cell Cancer Vaccine Sales by Application (2017-2022) & (K Doses)

Table 41. Americas Dendritic Cell Cancer Vaccine Sales Market Share by Application (2017-2022)

Table 42. APAC Dendritic Cell Cancer Vaccine Sales by Region (2017-2022) & (K Doses)

Table 43. APAC Dendritic Cell Cancer Vaccine Sales Market Share by Region (2017-2022)

Table 44. APAC Dendritic Cell Cancer Vaccine Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Dendritic Cell Cancer Vaccine Revenue Market Share by Region (2017-2022)

Table 46. APAC Dendritic Cell Cancer Vaccine Sales by Type (2017-2022) & (K Doses)

Table 47. APAC Dendritic Cell Cancer Vaccine Sales Market Share by Type (2017-2022)

Table 48. APAC Dendritic Cell Cancer Vaccine Sales by Application (2017-2022) & (K Doses)

Table 49. APAC Dendritic Cell Cancer Vaccine Sales Market Share by Application (2017-2022)

Table 50. Europe Dendritic Cell Cancer Vaccine Sales by Country (2017-2022) & (K Doses)

Table 51. Europe Dendritic Cell Cancer Vaccine Sales Market Share by Country (2017-2022)

Table 52. Europe Dendritic Cell Cancer Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Dendritic Cell Cancer Vaccine Revenue Market Share by Country (2017-2022)

Table 54. Europe Dendritic Cell Cancer Vaccine Sales by Type (2017-2022) & (K Doses)

Table 55. Europe Dendritic Cell Cancer Vaccine Sales Market Share by Type (2017-2022)

Table 56. Europe Dendritic Cell Cancer Vaccine Sales by Application (2017-2022) & (K Doses)

Table 57. Europe Dendritic Cell Cancer Vaccine Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Dendritic Cell Cancer Vaccine Sales by Country (2017-2022) & (K Doses)

Table 59. Middle East & Africa Dendritic Cell Cancer Vaccine Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Dendritic Cell Cancer Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Dendritic Cell Cancer Vaccine Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Dendritic Cell Cancer Vaccine Sales by Type (2017-2022) & (K Doses)

Table 63. Middle East & Africa Dendritic Cell Cancer Vaccine Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Dendritic Cell Cancer Vaccine Sales by Application (2017-2022) & (K Doses)

Table 65. Middle East & Africa Dendritic Cell Cancer Vaccine Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Dendritic Cell Cancer Vaccine

Table 67. Key Market Challenges & Risks of Dendritic Cell Cancer Vaccine

Table 68. Key Industry Trends of Dendritic Cell Cancer Vaccine

Table 69. Dendritic Cell Cancer Vaccine Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Dendritic Cell Cancer Vaccine Distributors List

Table 72. Dendritic Cell Cancer Vaccine Customer List

Table 73. Global Dendritic Cell Cancer Vaccine Sales Forecast by Region (2023-2028) & (K Doses)

Table 74. Global Dendritic Cell Cancer Vaccine Sales Market Forecast by Region

Table 75. Global Dendritic Cell Cancer Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Dendritic Cell Cancer Vaccine Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Dendritic Cell Cancer Vaccine Sales Forecast by Country (2023-2028) & (K Doses)

Table 78. Americas Dendritic Cell Cancer Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Dendritic Cell Cancer Vaccine Sales Forecast by Region (2023-2028) & (K Doses)

Table 80. APAC Dendritic Cell Cancer Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Dendritic Cell Cancer Vaccine Sales Forecast by Country (2023-2028) & (K Doses)

Table 82. Europe Dendritic Cell Cancer Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Dendritic Cell Cancer Vaccine Sales Forecast by Country (2023-2028) & (K Doses)

Table 84. Middle East & Africa Dendritic Cell Cancer Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Dendritic Cell Cancer Vaccine Sales Forecast by Type (2023-2028) & (K Doses)

Table 86. Global Dendritic Cell Cancer Vaccine Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Dendritic Cell Cancer Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Dendritic Cell Cancer Vaccine Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Dendritic Cell Cancer Vaccine Sales Forecast by Application (2023-2028) & (K Doses)

Table 90. Global Dendritic Cell Cancer Vaccine Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Dendritic Cell Cancer Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Dendritic Cell Cancer Vaccine Revenue Market Share Forecast by Application (2023-2028)

Table 93. Activarti Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 94. Activarti Dendritic Cell Cancer Vaccine Product Offered

Table 95. Activarti Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 96. Activarti Main Business

Table 97. Activarti Latest Developments

Table 98. Argos Therapeutics Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 99. Argos Therapeutics Dendritic Cell Cancer Vaccine Product Offered

Table 100. Argos Therapeutics Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 101. Argos Therapeutics Main Business

Table 102. Argos Therapeutics Latest Developments

Table 103. SOTIO (Acquired by PPF Group) Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 104. SOTIO (Acquired by PPF Group) Dendritic Cell Cancer Vaccine Product Offered

Table 105. SOTIO (Acquired by PPF Group) Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 106. SOTIO (Acquired by PPF Group) Main Business

Table 107. SOTIO (Acquired by PPF Group) Latest Developments

Table 108. Bellicum Pharmaceuticals Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 109. Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Product Offered

Table 110. Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 111. Bellicum Pharmaceuticals Main Business

Table 112. Bellicum Pharmaceuticals Latest Developments

Table 113. JW CreaGene Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 114. JW CreaGene Dendritic Cell Cancer Vaccine Product Offered

Table 115. JW CreaGene Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 116. JW CreaGene Main Business

Table 117. JW CreaGene Latest Developments

Table 118. DanDrit Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 119. DanDrit Dendritic Cell Cancer Vaccine Product Offered

Table 120. DanDrit Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 121. DanDrit Main Business

Table 122. DanDrit Latest Developments

Table 123. DCPrime Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 124. DCPrime Dendritic Cell Cancer Vaccine Product Offered

Table 125. DCPrime Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 126. DCPrime Main Business

Table 127. DCPrime Latest Developments

Table 128. Elios Therapeutics Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 129. Elios Therapeutics Dendritic Cell Cancer Vaccine Product Offered

Table 130. Elios Therapeutics Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 131. Elios Therapeutics Main Business

Table 132. Elios Therapeutics Latest Developments

Table 133. ImmunoCellular Therapeutics Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 134. ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccine Product Offered

Table 135. ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 136. ImmunoCellular Therapeutics Main Business

Table 137. ImmunoCellular Therapeutics Latest Developments

Table 138. Kiromic Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 139. Kiromic Dendritic Cell Cancer Vaccine Product Offered

Table 140. Kiromic Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 141. Kiromic Main Business

Table 142. Kiromic Latest Developments

Table 143. Medigene Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 144. Medigene Dendritic Cell Cancer Vaccine Product Offered

Table 145. Medigene Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 146. Medigene Main Business

Table 147. Medigene Latest Developments

Table 148. Merck Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 149. Merck Dendritic Cell Cancer Vaccine Product Offered

Table 150. Merck Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 151. Merck Main Business

Table 152. Merck Latest Developments

Table 153. Northwest Biotherapeutics Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 154. Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Product Offered

Table 155. Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 156. Northwest Biotherapeutics Main Business

Table 157. Northwest Biotherapeutics Latest Developments

Table 158. Immutep Limited Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 159. Immutep Limited Dendritic Cell Cancer Vaccine Product Offered

Table 160. Immutep Limited Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 161. Immutep Limited Main Business

Table 162. Immutep Limited Latest Developments

Table 163. Dendreon Corporation Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 164. Dendreon Corporation Dendritic Cell Cancer Vaccine Product Offered

Table 165. Dendreon Corporation Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 166. Dendreon Corporation Main Business

Table 167. Dendreon Corporation Latest Developments

Table 168. Oncobiomed Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 169. Oncobiomed Dendritic Cell Cancer Vaccine Product Offered

Table 170. Oncobiomed Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 171. Oncobiomed Main Business

Table 172. Oncobiomed Latest Developments

List of Figures

Figure 1. Picture of Dendritic Cell Cancer Vaccine

Figure 2. Dendritic Cell Cancer Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Dendritic Cell Cancer Vaccine Sales Growth Rate 2017-2028 (K Doses)

Figure 7. Global Dendritic Cell Cancer Vaccine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Dendritic Cell Cancer Vaccine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of CreaVax

Figure 10. Product Picture of Sipuleucel-T (Provenge)

Figure 11. Product Picture of Others

Figure 12. Global Dendritic Cell Cancer Vaccine Sales Market Share by Type in 2021

Figure 13. Global Dendritic Cell Cancer Vaccine Revenue Market Share by Type (2017-2022)

Figure 14. Dendritic Cell Cancer Vaccine Consumed in Pediatrics

Figure 15. Global Dendritic Cell Cancer Vaccine Market: Pediatrics (2017-2022) & (K Doses)

Figure 16. Dendritic Cell Cancer Vaccine Consumed in Adults

Figure 17. Global Dendritic Cell Cancer Vaccine Market: Adults (2017-2022) & (K Doses)

Figure 18. Global Dendritic Cell Cancer Vaccine Sales Market Share by Application (2017-2022)

Figure 19. Global Dendritic Cell Cancer Vaccine Revenue Market Share by Application in 2021

Figure 20. Dendritic Cell Cancer Vaccine Revenue Market by Company in 2021 ($ Million)

Figure 21. Global Dendritic Cell Cancer Vaccine Revenue Market Share by Company in 2021

Figure 22. Global Dendritic Cell Cancer Vaccine Sales Market Share by Geographic Region (2017-2022)

Figure 23. Global Dendritic Cell Cancer Vaccine Revenue Market Share by Geographic Region in 2021

Figure 24. Global Dendritic Cell Cancer Vaccine Sales Market Share by Region (2017-2022)

Figure 25. Global Dendritic Cell Cancer Vaccine Revenue Market Share by Country/Region in 2021

Figure 26. Americas Dendritic Cell Cancer Vaccine Sales 2017-2022 (K Doses)

Figure 27. Americas Dendritic Cell Cancer Vaccine Revenue 2017-2022 ($ Millions)

Figure 28. APAC Dendritic Cell Cancer Vaccine Sales 2017-2022 (K Doses)

Figure 29. APAC Dendritic Cell Cancer Vaccine Revenue 2017-2022 ($ Millions)

Figure 30. Europe Dendritic Cell Cancer Vaccine Sales 2017-2022 (K Doses)

Figure 31. Europe Dendritic Cell Cancer Vaccine Revenue 2017-2022 ($ Millions)

Figure 32. Middle East & Africa Dendritic Cell Cancer Vaccine Sales 2017-2022 (K Doses)

Figure 33. Middle East & Africa Dendritic Cell Cancer Vaccine Revenue 2017-2022 ($ Millions)

Figure 34. Americas Dendritic Cell Cancer Vaccine Sales Market Share by Country in 2021

Figure 35. Americas Dendritic Cell Cancer Vaccine Revenue Market Share by Country in 2021

Figure 36. United States Dendritic Cell Cancer Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 37. Canada Dendritic Cell Cancer Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 38. Mexico Dendritic Cell Cancer Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 39. Brazil Dendritic Cell Cancer Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 40. APAC Dendritic Cell Cancer Vaccine Sales Market Share by Region in 2021

Figure 41. APAC Dendritic Cell Cancer Vaccine Revenue Market Share by Regions in 2021

Figure 42. China Dendritic Cell Cancer Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 43. Japan Dendritic Cell Cancer Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 44. South Korea Dendritic Cell Cancer Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 45. Southeast Asia Dendritic Cell Cancer Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 46. India Dendritic Cell Cancer Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 47. Australia Dendritic Cell Cancer Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 48. Europe Dendritic Cell Cancer Vaccine Sales Market Share by Country in 2021

Figure 49. Europe Dendritic Cell Cancer Vaccine Revenue Market Share by Country in 2021

Figure 50. Germany Dendritic Cell Cancer Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 51. France Dendritic Cell Cancer Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 52. UK Dendritic Cell Cancer Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 53. Italy Dendritic Cell Cancer Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 54. Russia Dendritic Cell Cancer Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 55. Middle East & Africa Dendritic Cell Cancer Vaccine Sales Market Share by Country in 2021

Figure 56. Middle East & Africa Dendritic Cell Cancer Vaccine Revenue Market Share by Country in 2021

Figure 57. Egypt Dendritic Cell Cancer Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 58. South Africa Dendritic Cell Cancer Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 59. Israel Dendritic Cell Cancer Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 60. Turkey Dendritic Cell Cancer Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 61. GCC Country Dendritic Cell Cancer Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 62. Manufacturing Cost Structure Analysis of Dendritic Cell Cancer Vaccine in 2021

Figure 63. Manufacturing Process Analysis of Dendritic Cell Cancer Vaccine

Figure 64. Industry Chain Structure of Dendritic Cell Cancer Vaccine

Figure 65. Channels of Distribution

Figure 66. Distributors Profiles